<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://www.msnewstoday.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.8" --><!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.1.5" --><!-- generated-on="October 27, 2009 12:50 pm" --><urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://www.msnewstoday.com/</loc>
		<lastmod>2009-10-27T19:49:21+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogens-tysabri-problems-the-fault-of-european-docs/</loc>
		<lastmod>2009-10-27T19:49:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/acorda-announces-positive-vote-by-fda-advisory-committee-for-fampridine-sr/</loc>
		<lastmod>2009-10-23T12:44:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/fda-delays-ruling-on-acordas-ms-drug-until-jan/</loc>
		<lastmod>2009-10-23T12:44:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/teva-sues-mylan-over-ms-drug-copaxone/</loc>
		<lastmod>2009-10-20T13:01:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/newly-published-data-show-copaxone-promoted-remyelination-of-damaged-axons/</loc>
		<lastmod>2009-10-20T12:59:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/a-new-cause-for-ms/</loc>
		<lastmod>2009-10-16T09:49:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/whats-the-point-of-extavia/</loc>
		<lastmod>2009-10-16T09:46:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/luteolin-as-a-therapeutic-option-for-ms/</loc>
		<lastmod>2009-10-14T15:47:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/avanir-posts-mixed-late-stage-zenvia-study-results/</loc>
		<lastmod>2009-10-12T17:17:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-walking-improvement-drug-receives-negative-fda-review/</loc>
		<lastmod>2009-10-12T17:07:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/copaxone-used-for-first-episodecis-halves-ms-risk/</loc>
		<lastmod>2009-10-08T11:23:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/merck-kgaa-submits-application-for-cladribine-tablets-in-us/</loc>
		<lastmod>2009-10-01T13:47:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/oral-alert-novartis-says-fty720-reduces-relapses/</loc>
		<lastmod>2009-09-30T09:08:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/regenerx%e2%80%99s-t%ce%b24-significantly-improves-functional-recovery-in-ms-animal-model/</loc>
		<lastmod>2009-09-30T09:07:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/merck-discontinues-ph-2-trial-of-atacicept-in-ms/</loc>
		<lastmod>2009-09-29T13:52:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/dont-hold-your-breath-for-generic-avonex/</loc>
		<lastmod>2009-09-22T17:53:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogen-reports-2-more-cases-of-pml-with-tysabri/</loc>
		<lastmod>2009-09-15T11:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-ectrims-press-alemtuzumab-shows-lasting-benefits/</loc>
		<lastmod>2009-09-13T12:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-and-diet-what-do-you-think/</loc>
		<lastmod>2009-09-12T12:43:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-ectrims-press-sanofi-oral-is-promising/</loc>
		<lastmod>2009-09-12T11:15:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-ectrims-press-fewer-injection-site-reactions-with-avonex/</loc>
		<lastmod>2009-09-11T21:44:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-ectrims-press-cladribine-significantly-reduces-disease-activity/</loc>
		<lastmod>2009-09-11T21:24:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-ectrims-press-play-your-brain-games/</loc>
		<lastmod>2009-09-02T10:18:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/no-flumist-for-people-with-multiple-sclerosis/</loc>
		<lastmod>2009-09-02T10:06:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/about/</loc>
		<lastmod>2009-09-02T09:36:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/avonex-pre-filled-syringes-and-side-effects/</loc>
		<lastmod>2009-09-01T15:37:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/mitoxantrone-is-highly-efficient-in-suppressing-ms/</loc>
		<lastmod>2009-09-01T14:56:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/swedish-snuff-doesn%e2%80%99t-increase-ms-risk/</loc>
		<lastmod>2009-09-01T14:46:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-ectrims-press-peptimmune-completes-ph-1b-study-of-pi-2301/</loc>
		<lastmod>2009-08-27T14:22:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/human-protein-may-hold-clues-to-new-ms-treatment/</loc>
		<lastmod>2009-08-25T14:14:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-patients-who-smoke-show-more-brain-atrophy-more-lesions-than-ms-nonsmokers/</loc>
		<lastmod>2009-08-21T12:25:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/generic-betaseron-is-wins-fda-approval/</loc>
		<lastmod>2009-08-18T15:59:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/researchers-successfully-reverse-ms-in-animals/</loc>
		<lastmod>2009-08-12T17:03:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/elan-and-biogen-are-in-a-fight/</loc>
		<lastmod>2009-08-10T19:11:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/facet-biotech-announces-daclizumab-ms-program-to-advance/</loc>
		<lastmod>2009-08-04T14:49:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/dirucotide-does-not-meet-primary-endpoint-in-phase-iii-trial-in-secondary-progressive-ms/</loc>
		<lastmod>2009-07-27T23:46:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/11th-case-of-pml-reported-with-tysabri/</loc>
		<lastmod>2009-07-26T14:23:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ribavirin-as-potential-treatment-for-ms/</loc>
		<lastmod>2009-07-23T19:48:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/merck-sumbits-cladribine-app-for-eu/</loc>
		<lastmod>2009-07-23T16:27:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/predicting-relapses-means-preventing-them/</loc>
		<lastmod>2009-07-23T16:18:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/nih-deepens-investment-in-avonex-and-copaxone-combination-study/</loc>
		<lastmod>2009-07-22T18:57:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/exercise-your-brain-online-game-launched-for-pwms/</loc>
		<lastmod>2009-07-20T17:24:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/smoking-probably-accelerates-ms/</loc>
		<lastmod>2009-07-14T22:51:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/as-lilly-pfizer-lobby-against-obama-healthcare-plan-their-execs-enjoy-gold-plated-coverage/</loc>
		<lastmod>2009-07-11T15:04:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/tired-of-patients-vs-profits-quit-throwing-fuel-on-the-fire/</loc>
		<lastmod>2009-07-10T16:20:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/take-betaseron-get-paid/</loc>
		<lastmod>2009-07-08T18:18:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/confirmed-bayer-will-pay-you-to-take-betaseron/</loc>
		<lastmod>2009-07-08T18:17:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/msuncertainty-definitely-but-things-may-have-just-gotten-a-little-clearer/</loc>
		<lastmod>2009-07-08T18:16:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/provigil-more-addictive-than-previously-thought-jurys-still-out/</loc>
		<lastmod>2009-07-08T18:15:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/nuvigil-coming-to-pharmacies-near-you-q3-2009/</loc>
		<lastmod>2009-07-08T18:15:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/have-pain-b12-and-cod-liver-oil-may-help/</loc>
		<lastmod>2009-07-08T18:14:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-and-diet-chewing-through-the-fluff/</loc>
		<lastmod>2009-07-08T18:13:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/malaria-pills-spell-the-end-of-pml/</loc>
		<lastmod>2009-07-08T18:12:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogen-hopes-to-have-pml-related-test-by-year-end/</loc>
		<lastmod>2009-07-08T18:12:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/patients-suffer-as-a-result-of-insurance-pricing-scheme/</loc>
		<lastmod>2009-07-08T18:11:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/late-breaking-new-phase-iii-data-for-cladribine-to-be-presented-at-aan/</loc>
		<lastmod>2009-07-08T18:10:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/pwms-have-a-lower-cancer-risk/</loc>
		<lastmod>2009-07-08T18:09:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/first-clinical-episode-watch-cis-for-you-seasoned-readers/</loc>
		<lastmod>2009-07-08T18:06:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/stem-cells-are-back-in-the-game/</loc>
		<lastmod>2009-07-08T18:05:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hookworms-ms-and-you/</loc>
		<lastmod>2009-07-08T18:05:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-oral-drug-laquinimod-begins-phase-iii-trials/</loc>
		<lastmod>2009-07-08T18:03:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/possible-link-between-epstein-barr-and-ms/</loc>
		<lastmod>2009-07-08T17:59:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/t-cells-and-b-cells-what-they-mean-to-you/</loc>
		<lastmod>2009-07-08T17:56:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/be-aware-in-march-its-ms-awareness-month/</loc>
		<lastmod>2009-07-08T17:55:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/the-age-of-orals-who-will-win-the-race-to-the-market/</loc>
		<lastmod>2009-07-08T17:54:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/experimental-ms-drug-may-aid-walking/</loc>
		<lastmod>2009-07-08T17:53:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/heat-reactions-in-multiple-sclerosis-an-overlooked-paradigm-in-the-study-of-comparative-fatigue/</loc>
		<lastmod>2009-07-08T17:51:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/novartis-ms-drug-linked-to-new-side-effect/</loc>
		<lastmod>2009-07-08T17:50:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogen-receives-fda-warning-for-tysabri-re-internet-ads/</loc>
		<lastmod>2009-07-08T17:47:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/cat-got-yourimmune-system/</loc>
		<lastmod>2009-07-08T17:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-patients-arent-the-only-ones-who-get-pml-because-of-drugs/</loc>
		<lastmod>2009-07-08T17:46:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/genetically-modified-stem-cells-treat-autoimmune-disease/</loc>
		<lastmod>2009-07-08T17:45:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/stem-cell-breakthrough-may-lead-to-ms-treatments/</loc>
		<lastmod>2009-07-08T17:44:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/11-ms-drugs-may-soon-be-on-pharmacy-shelves-or-infusion-suites-near-you/</loc>
		<lastmod>2009-07-08T17:43:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/study-suggests-copaxone-has-protective-effects/</loc>
		<lastmod>2009-07-08T17:42:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-fat-cells-and-you/</loc>
		<lastmod>2009-07-08T17:40:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/site-of-ms-onset-usually-location-of-relapse/</loc>
		<lastmod>2009-07-08T17:39:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/tysabri-may-reverse-ms-damage/</loc>
		<lastmod>2009-07-08T17:36:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/fingolimod-effective-but-safety-an-issue/</loc>
		<lastmod>2009-07-08T17:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/laquinimod-new-data-moa/</loc>
		<lastmod>2009-07-08T17:33:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/cladribine-reduces-relapses-disability-disease-progression/</loc>
		<lastmod>2009-07-08T17:32:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/novantrone-linked-to-many-more-cases-of-leukemia/</loc>
		<lastmod>2009-07-08T17:32:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/adding-steroid-to-interferon-may-slow-disease-activity/</loc>
		<lastmod>2009-07-08T17:30:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/fampridine-sr-receives-priority-fda-review-for-walking-drug/</loc>
		<lastmod>2009-07-08T17:28:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/marijuana-may-slow-ms/</loc>
		<lastmod>2009-07-08T17:27:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/treating-ms-with-natural-remedies/</loc>
		<lastmod>2009-07-08T17:27:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/diabetes-drug-may-aid-multiple-sclerosis/</loc>
		<lastmod>2009-07-08T17:25:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-a-cause-for-concern/</loc>
		<lastmod>2009-07-08T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogen-says-eighth-patient-has-infection-from-tysabri/</loc>
		<lastmod>2009-07-08T17:16:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/more-power-to-you-nyu/</loc>
		<lastmod>2009-07-08T17:15:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/1-in-4-ms-patients-dont-fill-scripts/</loc>
		<lastmod>2009-07-08T17:14:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/cigarettes-and-ms-more-evidence-of-a-bad-combination/</loc>
		<lastmod>2009-07-08T17:13:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-aan-press-belatedly-high-doses-of-vitamin-d-cut-ms-relapses/</loc>
		<lastmod>2009-07-08T17:12:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogen-enrolls-patients-in-new-ms-trial/</loc>
		<lastmod>2009-07-08T17:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/tysabri-side-effects-linked-to-9th-pml-infection-case/</loc>
		<lastmod>2009-07-08T17:10:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/cladribine-is-safe-overall-in-patients-with-multiple-sclerosis-presented-at-ens/</loc>
		<lastmod>2009-07-08T17:09:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/figuring-out-who-will-benefit-most-from-a-new-ms-therapy/</loc>
		<lastmod>2009-07-08T17:08:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/learning-increases-myelination/</loc>
		<lastmod>2009-07-08T17:07:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-ens-pressimmunomodulatory/</loc>
		<lastmod>2009-07-08T17:07:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/teva-completes-enrollment-in-second-phase-iii-trial/</loc>
		<lastmod>2009-07-08T17:06:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/10th-pml-case-confirmed-by-biogen/</loc>
		<lastmod>2009-07-08T17:06:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-ens-pressrebif-autoinject-improves-sc-delivery/</loc>
		<lastmod>2009-07-08T17:05:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogen-reports-13th-case-of-pml/</loc>
		<lastmod>2009-07-08T17:04:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/clay-walkers-bams-foundation-donates-150k-to-support-ms-research/</loc>
		<lastmod>2009-07-08T17:04:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/hot-off-the-aan-press-tysabri-promotes-remyelination/</loc>
		<lastmod>2009-07-08T17:02:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/first-10-year-follow-up-shows-that-avonex%c2%ae-leads-to-long-term-benefits-in-early-ms-pts/</loc>
		<lastmod>2009-07-08T17:01:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/aan-2009-early-exposure-to-smoking-boosts-multiple-sclerosis-risk/</loc>
		<lastmod>2009-07-08T16:59:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/link-between-autism-and-maternal-autoimmune-disease/</loc>
		<lastmod>2009-07-08T16:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogen-receives-fda-fast-track-for-pegylated-interferon-beta-1a/</loc>
		<lastmod>2009-07-08T16:18:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biogen-idec-announces-sixth-case-of-pml-linked-to-use-of-tysabri/</loc>
		<lastmod>2009-04-22T15:20:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/biomss-phase-iii-us-ms-trial-receives-positive-safety-review-from-data-safety-monitoring-board/</loc>
		<lastmod>2009-04-14T15:30:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/product-overview-dirucotide/</loc>
		<lastmod>2009-04-14T15:27:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/new-section-managing-your-symptoms-bladder/</loc>
		<lastmod>2009-03-31T15:20:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/132/</loc>
		<lastmod>2009-03-24T16:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/spms-treatment-update-spotlight-on-dirucotide-bioms-medical-corp/</loc>
		<lastmod>2009-03-17T15:09:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/breast-feeding-works-miracles-for-both-baby-and-mother-with-ms/</loc>
		<lastmod>2009-03-14T22:48:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/daclizumab-shows-promise-in-ph-ii-trial/</loc>
		<lastmod>2009-03-12T16:24:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/daclizumab-and-interferon-next-wave-combination-therapy/</loc>
		<lastmod>2009-03-12T16:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/ms-society-research-summary-march-2009/</loc>
		<lastmod>2009-03-10T18:41:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/nbc-today-show-nbc-today-show-where-are-we-with-ms/</loc>
		<lastmod>2009-03-09T22:21:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/maintaining-a-healthy-lifestyle-with-ms/</loc>
		<lastmod>2009-03-09T17:47:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.msnewstoday.com/both-cortical-and-subcortical-atrophy-involved-in-amnesia-of-ms/</loc>
		<lastmod>2009-03-08T19:04:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
</urlset>